Results 31 to 40 of about 3,363,784 (294)

E2F3 is responsible for frequent amplification of 6p22.3 in human bladder cancer [PDF]

open access: yes, 2007
The 6p22 is generally regarded as one of the most important amplification sites in urinary bladder cancer. Investigations, encouraged by these findings, subsequently lead to the delineation of the amplicon.
Oeggerli, Martin
core   +1 more source

Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2021
Bladder cancer (BC) is the 10 th most common malignancy worldwide and the patient experience is found to be worse than that for patients diagnosed with other cancer types.
Agustina Bessa   +26 more
doaj   +1 more source

The call for a strategic framework to improve cancer literacy in Europe

open access: yesArchives of Public Health, 2020
Background Health literacy is increasingly being recognized as a widespread public health challenge in Europe. This commentary explores the importance of health literacy amongst cancer patients (ie, cancer literacy) and examines how cancer literacy can ...
Kristine Sørensen   +6 more
doaj   +1 more source

Bladder Cancer [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2013
Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of ...
Peter E, Clark   +26 more
openaire   +2 more sources

Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy [PDF]

open access: yes, 1999
Purpose: We determined whether neoplastic disease, which was missed under white light can be found during transurethral resection of bladder cancer by 5-aminolevulinic acid-induced porphyrin fluorescence.
Kriegmair, Martin   +13 more
core   +1 more source

Outcomes and Therapeutic Management of Bladder Cancer [PDF]

open access: yes, 2020
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection ...

core   +1 more source

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci [PDF]

open access: yes, 2010
We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which ...
Taylor JA   +611 more
core   +2 more sources

Quality of Life and Health State Utilities in Bladder Cancer

open access: yes, 2022
Background: Bladder cancer treatments may variably impact health-related quality of life (QOL). Objective: To characterize the quality of life of patients with bladder cancer at various time points across the continuum of bladder cancer care from non ...
Amy Guo   +17 more
core   +1 more source

Intrinsic subtypes and bladder cancer metastasis

open access: yesAsian Journal of Urology, 2016
Recent studies demonstrated that bladder cancers can be grouped into basal and luminal molecular subtypes that possess distinct biological and clinical characteristics.
David J. McConkey   +3 more
doaj   +1 more source

Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma

open access: yesDiagnostics
Background/Objectives: Clear-cell renal cell carcinoma (ccRCC) represents the predominant histologic subtype of renal cancer and poses persistent diagnostic challenges, particularly in the evaluation of small renal masses, where conventional imaging and ...
Daniel A. González-Padilla   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy